<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment of three lines of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells (epidermoid <z:mp ids='MP_0002038'>carcinoma</z:mp>: HeLa-S3, and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>: Daudi and P3HR-1) with human alpha or beta interferon (HuIFN-alpha or HuIFN-beta) results in inhibition of cell proliferation as well as in increased modal cell volume and <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of the populations with respect to cell volume </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> three cell lines the IFN-alpha- or IFN-beta-induced changes in cell proliferation and in cell volume are inversely related to each other </plain></SENT>
<SENT sid="2" pm="."><plain>However, these lines differ significantly in their sensitivity to the effects of IFN-alpha and IFN-beta </plain></SENT>
</text></document>